phenyl acetate has been researched along with Phosphorus Metabolism Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
| Nolan, CR; Qunibi, WY | 1 |
| Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
| Chou, CY; Huang, CC; Kuo, HL; Liao, PY; Lin, HH; Lin, PW; Liu, JH; Liu, YL; Yang, YF; Yu, CC | 1 |
| Dayton, KD | 1 |
| d'Almeida Filho , EJ; da Cruz, EA; Hoette, M; Keen, LN; Lugon, JR; Ruzany, F | 1 |
| Malluche, HH; Mawad, H | 1 |
2 review(s) available for phenyl acetate and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study.
Topics: Acetates; Calcium; Calcium Compounds; Double-Blind Method; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis | 2004 |
Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions.
Topics: Acetates; Calcium Compounds; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders | 2002 |
3 trial(s) available for phenyl acetate and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Analysis of Variance; Biomarkers; Bone Remodeling; Calcium; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Research Design; Sevelamer; Treatment Outcome | 2006 |
Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Adult; Analysis of Variance; Antacids; Calcium Carbonate; Cross-Over Studies; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus Metabolism Disorders; Renal Dialysis | 2000 |
2 other study(ies) available for phenyl acetate and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
Calcium acetate: a choice for phosphate management.
Topics: Acetates; Acetic Acid; Drug Interactions; Humans; Phosphorus Metabolism Disorders; Renal Dialysis; Renal Insufficiency | 1996 |